UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study

Head & neck, 2021-11, Vol.43 (11), p.3408-3416

2021

Volltextzugriff (PDF)

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Head & neck, 2023-01, Vol.45 (1), p.212-224

2023

Volltextzugriff (PDF)

Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient

Head & neck, 2020-10, Vol.42 (10), p.E16-E22

2020

Volltextzugriff (PDF)

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective

Cancer medicine (Malden, MA), 2020-09, Vol.9 (17), p.6141-6146

2020

Volltextzugriff (PDF)

Papillomavirus E6 and E7 proteins and their cellular targets

Frontiers in bioscience, 2008-01, Vol.13 (13), p.1003

2008

Volltextzugriff (PDF)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

Frontiers in immunology, 2023-03, Vol.14, p.1184007-1184007

2023

Volltextzugriff (PDF)

Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis

Cancers, 2021-07, Vol.13 (15), p.3677

2021

Volltextzugriff (PDF)

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3217

2024

Volltextzugriff (PDF)

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia

Haematologica (Roma), 2023-03, Vol.108 (3), p.705-716

2023

Volltextzugriff (PDF)

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005632

2022

Volltextzugriff (PDF)

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity

Cancers, 2022-07, Vol.14 (15), p.3564

2022

Volltextzugriff (PDF)

Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes

Cancers, 2021-12, Vol.13 (24), p.6309

2021

Volltextzugriff (PDF)

A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8 + T Cells in Head and Neck Cancer

Frontiers in pharmacology, 2020-02, Vol.11, p.143

2020

Volltextzugriff (PDF)

Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma

Cancers, 2024-02, Vol.16 (5), p.1008

2024

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors Regulate K+ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients

Frontiers in pharmacology, 2021-08, Vol.12, p.742862-742862

2021

Volltextzugriff (PDF)

Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

Cancer discovery, 2020-05, Vol.10 (5), p.688-701

2020

Volltextzugriff (PDF)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Cancers, 2022-05, Vol.14 (10), p.2355

2022

Volltextzugriff (PDF)

Human papillomavirus induced transformation in cervical and head and neck cancers

Cancers, 2014-09, Vol.6 (3), p.1793-1820

2014

Volltextzugriff (PDF)

Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients

Cancers, 2021-09, Vol.13 (19), p.4861

2021

Volltextzugriff (PDF)

Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells

Molecular therapy. Methods & clinical development, 2021-06, Vol.21, p.133-143

2021

Volltextzugriff (PDF)

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Molecular and Cellular Biology, 2006-10, Vol.26 (20), p.7506-7519

2006

Volltextzugriff (PDF)

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1792-1799

2009

Volltextzugriff (PDF)

Managing Recurrent Metastatic Head and Neck Cancer

Hematology/oncology clinics of North America, 2021-10, Vol.35 (5), p.1009-1020

2021

Volltextzugriff (PDF)

Future directions and treatment strategies for head and neck squamous cell carcinomas

Translational research : the journal of laboratory and clinical medicine, 2012-09, Vol.160 (3), p.167-177

2012

Volltextzugriff (PDF)

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Clinical cancer research, 2023-05, Vol.29 (10), p.1906-1915

2023

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

KollektionNexis

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective

Papillomavirus E6 and E7 proteins and their cellular targets

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity

Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes

A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8 + T Cells in Head and Neck Cancer

Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma

Immune Checkpoint Inhibitors Regulate K+ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients

Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Human papillomavirus induced transformation in cervical and head and neck cancers

Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients

Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

Managing Recurrent Metastatic Head and Neck Cancer

Future directions and treatment strategies for head and neck squamous cell carcinomas

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Aktive Filter

Suchergebnisse filtern